Sankalp Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 24-12-2024
- Paid Up Capital ₹ 5.00 M
as on 24-12-2024
- Company Age 29 Year, 9 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 3.34 Cr
as on 24-12-2024
- Satisfied Charges ₹ 3.09 Cr
as on 24-12-2024
- Revenue -4.85%
(FY 2020)
- Profit 5.89%
(FY 2020)
- Ebitda -133.93%
(FY 2020)
- Net Worth 6.67%
(FY 2020)
- Total Assets 5.30%
(FY 2020)
About Sankalp Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹3.34 Cr. The company has closed loans amounting to ₹3.09 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pralhad Khadangle and Rattanmala Khadangle serve as directors at the Company.
- CIN/LLPIN
U15140MH1995PTC086733
- Company No.
086733
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Mar 1995
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sankalp Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pralhad Khadangle  | Director | 23-Mar-1995 | Current |
| Rattanmala Khadangle | Director | 23-Mar-1995 | Current |
Financial Performance of Sankalp Biotech.
Sankalp Biotech Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 4.85% decrease. The company also saw a slight improvement in profitability, with a 5.89% increase in profit. The company's net worth moved up by a moderate rise of 6.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sankalp Biotech?
In 2021, Sankalp Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sungrace-Ag Biochemicals Private LimitedActive 14 years 10 monthsPralhad Khadangle is a mutual person
- Vinchur Wine Park Processor & Farmers Facility CentreActive 19 years 3 months
Pralhad Khadangle is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 08 Mar 2019 | ₹3.34 Cr | Open |
Dena Bank Creation Date: 29 Apr 2016 | ₹2.00 Cr | Satisfied |
Dena Bank Creation Date: 19 Dec 2015 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Sankalp Biotech?
Unlock and access historical data on people associated with Sankalp Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sankalp Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sankalp Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
